Ads
related to: lung cancer, study
Search results
Phase III trial shows lorlatinib highly effective against ALK-positive non–small cell lung cancer
Medical Xpress· 1 day agoA large team of medical researchers and doctors has found via phase III clinical trial that the ALK inhibitor lorlatinib is highly effective for treating non–small cell lung
Newswise Expert | Puneeth Iyengar, UT Southwestern Medical Center
Newswise· 20 hours agoBriefly, Puneeth Iyengar joined the UT Southwestern Medical Center in Dallas, TX USA in the summer of 2010 and is currently an Assistant Professor of Radiation Oncology, with a professional ...
Virtual and In-Person Palliative Care Equally Beneficial in Advanced Lung Cancer
MedPage Today· 4 days agoFurther, patient and caregiver-reported satisfaction with care and patient-reported anxiety and...
...Result from Phase II Trial for First-line NSCLC Treatment in KROCUS Study, fulzerasib (KRAS G12C...
Forrest City Times-Herald· 4 days agoGenFleet Therapeutics, a clinical-stage biotechnology company focusing on cutting-edge therapies in oncology and immunology, today announced the phase II trial data of KROCUS Study& ...
Summit Therapeutics cancer therapy succeeds in late-stage China study
WSAU Wausau· 6 days ago(Reuters) - Summit Therapeutics said on Thursday its experimental therapy to treat patients with a type of lung cancer met the main goal of a late-stage ...
Late-breaking results from PALOMA-2 study of subcutaneous amivantamab in combination with lazertinib...
Forrest City Times-Herald· 2 days agoJohnson & Johnson announced today new data from the Phase 2 PALOMA-2 study evaluating subcutaneous (SC) amivantamab combined with lazertinib as a first-line treatment in patients ...
EMA CHMP recommends AstraZeneca’s Tagrisso for lung cancer
Pharmaceutical Technology via Yahoo Finance· 2 days agoThe Tagrisso regimen is intended for treating patients with locally advanced or metastatic epidermal...
Breaking down barriers: ROCK2 inhibition facilitates drug delivery in fibrotic pancreatic cancer
Medical Xpress· 2 hours agoPancreatic cancer, recognized as one of the deadliest cancers, poses a persistent challenge for medical professionals globally due to its aggressive behavior ...
Mobile app effective in smoking cessation, triples chance of success
Medical Xpress· 5 days agoA study conducted at Oulu University Hospital found that using the application tripled the success...
Bristol’s $250,000 Pill Slows Lung Cancer Growth by Seven Weeks
Bloomberg· 4 days agoHave a confidential tip for our reporters? A Bristol Myers Squibb Co. lung cancer treatment delayed...